Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 05, 2015 12:38 AM ET

Company Overview of ForSight VISION5, Inc.

Company Overview

ForSight VISION5, Inc. evaluates technologies to address patient needs in key ophthalmic markets. The company was incorporated in 2010 and is based in Menlo Park, California.

191 Jefferson Drive

Menlo Park, CA 94025

United States

Founded in 2010



Key Executives for ForSight VISION5, Inc.

Chief Executive Officer, President and Director
Vice President of Finance
Chief Medical Officer
Vice President of Marketing
Compensation as of Fiscal Year 2015.

ForSight VISION5, Inc. Key Developments

ForSight VISION5, Inc. Appoints Hector Casab as Vice President of Finance, Effective July 13, 2015

ForSight VISION5, Inc. announced the appointment of senior finance executive Hector Casab as Vice President of Finance, effective July 13, 2015. Mr. Casab joins ForSight VISION5 from ophthalmic pharmaceutical company Icon Bioscience, Inc., where as Vice President of Finance and Administration he oversaw all aspects of finance, operations, and administration. Mr. Casab was previously Senior Director, Financial Planning and Analysis, at Onyx Pharmaceuticals, Inc., providing financial management and leadership during Onyx's rapid growth leading up to its acquisition by Amgen. During his five-plus year tenure at Genentech, Mr. Casab's multiple roles included Director, Corporate Planning, Director, Global Supply Chain Finance, and Associate Director, Manufacturing Collaborations Finance. He was previously with Applied Biosystems, serving in various roles in operations and finance.

ForSight VISION5 Announces Completion of Enrollment of Phase 2 Dose-Ranging Study

ForSight VISION5 announced the completion of enrollment of 121 subjects in its Phase 2 dose-ranging study, and presentation of Phase 1b data at the World Glaucoma Congress in Hong Kong. The presented data demonstrated that a single administration of its investigational HeliosTM bimatoprost ocular insert provided sustained reduction in intraocular pressure (IOP) for six months. ForSight VISION5 is developing non-invasive ophthalmic products that are designed to replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The Phase 1b data were collected from a multicenter, prospective, single-arm, open-label, pooled analysis of the bimatoprost ocular insert. The data were presented by Prof. Ivan Goldberg, principal investigator of the Australian study. In this analysis of 27 subjects who met eligibility criteria, mean diurnal IOP at washout was 23.9 mmHg and a mean sustained diurnal IOP reduction of 4.7-6.5 mmHg was observed for 6 months. There were no reported serious or unexpected ocular adverse events. The company continues to advance the clinical development of the Helios insert. The Phase 2 dose-ranging study (FSV5-004) is a prospective, randomized, double-masked, controlled study designed to evaluate the efficacy, safety, and dose-response of two loading doses of the bimatoprost ocular insert compared to a control arm in subjects with open-angle glaucoma or ocular hypertension. The study enrolled 121 subjects at ten clinical sites in the USA in under nine weeks.

ForSight VISION5 Appoints Lisa Garrett as Vice President of Finance and Administration

ForSight VISION5 announced that Lisa Garrett has joined the company as Vice President of Finance and Administration from Medtronic. Earlier this year, Medtronic acquired Corventis, Inc., for which Ms. Garrett served as Chief Financial Officer and Vice President, Human Resources. Ms. Garrett brings over 20 years of diversified finance and human resources experience to ForSight VISION5.

Similar Private Companies By Industry

Company Name Region
Skyport Development Co Llc United States
Lou Hammond & Associates Inc. United States
Miami Air Conditioning Co. United States
Novacorp Realty Finance Ltd. United States
Archer Entertainment Media Communications Incorporated United States

Recent Private Companies Transactions

Private Placement
August 24, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ForSight VISION5, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at